Previous Page  31 / 42 Next Page
Information
Show Menu
Previous Page 31 / 42 Next Page
Page Background

Pain Management 2018

Internal Medicine 2018

International Journal of Anesthesiology & Pain Medicine

ISSN: 2471-982X

Page 82

March 26-28, 2018

Vienna, Austria

JOINT EVENT

7

t h

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Internal Medicine and Patient Care

&

6

t h

E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n

Pain Management

Volume 4

C

hronic kidney disease (CKD) is a common clinical problem in

elderly patients. Serum cystatin C is protein which suggested

to be an ideal marker of glomerular filtration rate (GFR). CKD is a

risk factor for dementia. We aimed to determine the serum levels

of cystatin C in patients with CKD and to correlate this with degree

of cognitive impairment and stages of kidney disease. 90 subjects

aged 65 years and older were involved, divided into two groups;

Group I: 60 patients with CKD, and Group II: 30 with age and sex

matched healthy participants. Patients with heart failure, hepatic

failure, thyroid disease, patients underwent dialysis for longer

than one month, patients had polycystic kidney disease, who had

bonemarrow transplant, and those receiving immunosuppressive

therapy with in the past six months were excluded from the

study. Mini-Mental scale (MMS), serum cyctatin level, stage

of CKD were done to all participants. Serum cystatin level was

significantly high in CKD patients. MMS score was significantly

lower in CKD patients. A high significant negative correlation was

found between serum cystatin C levels and degree of cognitive

impairment. Also a significant positive correlation was found

between levelsof cognitive impairment andGFR. Ahighsignificant

negative correlation was found between serum cystatin C levels

and GFR (R=-0.531, p <0.001). We concluded that serum cystatin

levels are significantly associated with cognitive impairment

in CKD patients, and this correlation becomes stronger with

advanced stages of CKD. That may help in better understanding

of the pathogenesis of dementia in CKD patients.

drmarwasaad74@gmail.com

Study of the association between cognition and levels of

cystatin C in elderly patients with chronic kidney disease

Marwa A Saad, Marwa A Waly, Suzan N Abo-Raya

and

Neveen L Saad

Alexandria University, Egypt

Int J Anesth Pain Med 2018, Volume 4

DOI: 10.21767/2471-982X-C1-003